Register

COURSE DESCRIPTION: 
Please join us for a conference on the Comprehensive Management of Persons with HIV in 2024 with William R. Short, M.D., MPH.
Dr. Short will discuss when to initiate an appropriate initial antiretroviral therapy regimen for people with HIV, and apply the latest recommendations –– Primary Care Guidance for Persons with HIV –– of the HIV Medicine Association of the Infectious Diseases Society of America to optimize care engagement, medication adherence and viral suppression in people with HIV.

TARGET AUDIENCE:
Internal Medicine Physicians, Pharmacists, Physician Assistants, Residents,  Advanced Practice Registered Nurses, and all other interested healthcare providers

LEARNING OBJECTIVES:

• Initiate an appropriate initial antiretroviral therapy regimen for people with HIV.
• Apply the latest recommendations –– Primary Care Guidance for Persons with HIV –– of the HIV Medicine Association of the Infectious Diseases Society of America to optimize care engagement, medication adherence and viral suppression in people with HIV.
• Implement recommendations from the Guidance, including those for management of comorbidities, such as heart disease and cancer and the associated challenges of polypharmacy.

FACULTY AND DISCLOSURES:

William R. Short, M.D., MPH, FIDSA
Associate Professor of Medicine 
Perelman School of Medicine at the University of Pennsylvania
Philadelphia, Pennsylvania

William R. Short, M.D., MPH, faculty for this educational activity, is a consultant and receives grants for Viiv and Gilead Sciences. He has indicated that the presentation or discussion will not include off-label or unapproved product usage. All of the relevant financial relationships listed for this individual have been mitigated.

John F. Rubin, M.D., FACP, director of this educational activity, has indicated that he is a shareholder in AstraZeneca and Bristol-Myers Squibb. All of the relevant financial relationships listed for this individual have been mitigated.

Non-faculty contributors and others involved in the planning, development and editing/review of the content have no relevant financial relationships with ineligible companies* to disclose.

*Ineligible companies – Companies whose primary business is producing, marketing, selling, re-selling or distributing healthcare products used by or on patients.
Disclosure Policy and Disclaimer

ACCREDITATION STATEMENTS AND CREDITS

Baptist Health South Florida is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians. Baptist Health has been re-surveyed by the ACCME and awarded Commendation for 6 years as a provider of CME for physicians.

Baptist Health South Florida designates this live activity for a maximum of 1 AMA PRA Category 1 Credit™.  Physicians should claim only the credit commensurate with the extent of their participation in the activity.   

This activity has been approved for 1 credit hour, CE Broker Course #20-855841, by the Florida Boards of Medicine, Podiatry, Osteopathic Medicine and Physician Assistants.  

This activity has also been approved for 1 credit for Nurse Practitioners, Nurses, Pharmacists and Pharmacy Techs, Athletic Trainers and Respiratory Techs. Baptist Health South Florida CE Broker Provider #50-182.